Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Medical College, Soochow University, Suzhou, 215000, China.
Stem Cell Res Ther. 2021 May 6;12(1):272. doi: 10.1186/s13287-021-02340-7.
Human cardiac organoids (hCOs), three-dimensional (3D) cellular constructs similar to in vivo organ, are new-generation models. To a large extent, a hCO retains the biological characteristics and functions of cells in vivo more accurately than previous models. With the continuous development of biotechnology, the hCO model is becoming increasingly complex and mature. High-fidelity hCOs help us better explore the mysteries of human physiology and integrate phenotypes with living functions into models. Here, we discuss recent advances in the methods of constructing human cardiac organoids and introduce applications of hCOs, especially in modeling cardiovascular diseases, including myocardial infarction, heart failure, genetic cardiac diseases, and arrhythmia. In addition, we propose the prospects for and the limitations of hCOs. In conclusion, a greater understanding of hCOs will provide ways to improve hCO construction and make these models useful for future preclinical studies.
人类心脏类器官(hCO)是类似于体内器官的三维(3D)细胞构建体,是新一代模型。在很大程度上,hCO 比以前的模型更准确地保留了体内细胞的生物学特征和功能。随着生物技术的不断发展,hCO 模型变得越来越复杂和成熟。高保真 hCO 有助于我们更好地探索人类生理学的奥秘,并将表型与活体功能整合到模型中。在这里,我们讨论了构建人类心脏类器官的方法的最新进展,并介绍了 hCO 的应用,特别是在模拟心血管疾病方面,包括心肌梗死、心力衰竭、遗传性心脏病和心律失常。此外,我们还提出了 hCO 的前景和局限性。总之,对 hCO 的进一步了解将为改善 hCO 构建提供途径,并使这些模型在未来的临床前研究中发挥作用。